Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung Cancer

Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung Cancer

The aim of this trial is to assess PD1-lymphocytes in bronchoalveolar lavage in patients with lung cancer, ILD and asthma.

In this trial, 20 patients with lung cancer, 10 patients with asthma and 10 patients with interstitial lung disease who have to undergo bronchocospy for medical reasons are enrolled. In each patient, bronchoalveolar lavage is performed to assess PD1-lymphocytes.

Inclusion Criteria:

• age >18 years
• patients with lung cancer, asthma or ILD and indication for bronchoscopy for medical reasons
• Ability to provide informed consent

Exclusion Criteria:

• acute excacerbation in patients with asthma or ILD
• endoluminal tumor growth or penumonia in patients with lung cancer